Serum ribonuclease in urologic cancer Relation to host immunocompetence (Q54732694)

3 June 2018

reason for preferred rank

title

Serum ribonuclease in urologic cancer Relation to host immunocompetence (English)

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

6 March 2023

Serum ribonuclease in urologic cancer. Relation to host immunocompetence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

6 March 2023

author name string

W. J. Catalona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

P. B. Chretien

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

W. J. Matthews

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

J. L. Tarpley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4797457

6 March 2023

language of work or name

English

0 references

publication date

1 November 1973

1 reference

3 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0090429573905761?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

https://api.elsevier.com/content/article/PII:0090429573905761?httpAccept=text/plain

6 March 2023

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

6 March 2023

1 reference

3 June 2018

volume

2

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

577-581

1 reference

3 June 2018

Immunologic unreactivity in bladder cancer patients

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

A new concept in the management of carcinoma of the prostate

6 March 2023

2

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

Serum Ribonuclease in Patients with Malignant Disease

6 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

Serum ribonucleases in cancer: Relation to tumor histology

6 March 2023

13

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

A method for dinitrochlorobenzene contact sensitization. A clinicopathological study

6 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

Quantitative dinitrochlorobenzene contact sensitization in a normal population

6 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

Plasma ribonuclease activity in human uremia

6 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

Serum proteins in prostatic cancer. I. Relationship between clinical stage and level

6 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

RNA-mediated transfer of tumor immunity —A new model for the immunotherapy of cancer

6 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0090-4295(73)90576-1

6 March 2023

Identifiers

1 reference

3 June 2018

1 reference

3 June 2018